Monopar Therapeutics Inc. (MNPR) has a market capitalization of $387.61M and trades at $57.92. The 52-week range is 26.055-105.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -31.3, Earnings Per Share (EPS) of $-1.85.
The stock has a beta of 1.59, operates in the Healthcare sector.
